Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;14(4):227-238.
doi: 10.2174/1573396314666180911100503.

The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: "It's About Time" or "Not so Fast" ?

Mong Tieng Ee  1 , Bernard Thébaud  1   2   3
Affiliations
Review

The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: "It's About Time" or "Not so Fast" ?

Mong Tieng Ee et al. Curr Pediatr Rev. 2018.

Abstract

Objective: While the survival of extremely premature infants has improved over the past decades, the rate of complications - especially for bronchopulmonary dysplasia (BPD) - remains unacceptably high. Over the past 50 years, no safe therapy has had a substantial impact on the incidence and severity of BPD.

Methods: This may stem from the multifactorial disease pathogenesis and the increasing lung immaturity. Mesenchymal Stromal Cells (MSCs) display pleiotropic effects and show promising results in neonatal rodents in preventing or rescuing lung injury without adverse effects. Early phase clinical trials are now underway to determine the safety and efficacy of this therapy in extremely premature infants.

Results and conclusion: This review summarizes our current knowledge about MSCs, their mechanism of action and the results of preclinical studies that provide the rationale for early phase clinical trials and discuss remaining gaps in our knowledge.

Keywords: MSCs; Therapeutic potential; angiogenesis; bronchopulmonary; dysplasia; stem cells..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Schematic diagram to illustrate the subsets of stem cells [18]:
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Stoll B.J., Hansen N.I., Bell E.F., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443–456. - PMC - PubMed
    1. Poindexter B.B., Feng R., Schmidt B., et al. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann. Am. Thorac. Soc. 2015;12(12):1822–1830. - PMC - PubMed
    1. Costeloe K.L., Hennessy E.M., Haider S., Stacey F., Marlow N., Draper E.S. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ. 2012;345:e7976. - PMC - PubMed
    1. Ancel P.Y., Goffinet F., Kuhn P., et al. Survival and morbidity of preterm children born at 22 through 34 weeks’ gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr. 2015;169(3):230–238. - PubMed
    1. Shah P.S., Sankaran K., Aziz K., et al. Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern? J. Perinatol. 2012;32(2):132–138. - PubMed

MeSH terms